Key facts
- Assort Health’s last known valuation is $700.0M (Aug 2025).
- It has raised $102.0M; the latest was Early Stage VC ($76.0M) in Aug 2025.
- Notable investors include Pioneer Fund, Lightspeed Venture Partners, Liquid 2 Ventures, Quiet Capital, Felicis — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Assort Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Assort Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Assort Health
Developer of a conversational artificial intelligence platform designed to augment and automate call center operations for health care for transforming patient care. The company's platform offers various features, including lower wait times, serving more patients, quality assurance, simple integration, secure data systems and seamless workflow, enabling the healthcare sector to reduce hold time, decrease dropped calls and reduce costs while driving appointment revenue.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Employees
- 77
- Website
- assorthealth.com/
- Ownership
- Privately Held (backing)
Assort Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Assort Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Assort Health in its N-PORT filings yet. We sweep new filings monthly.